The USFDA conducted Pre-Approval Inspection [PAI] of Torrent Pharmaceuticals Ltd's Oral-Oncology manufacturing facility at Bileshwarpura, Gujarat from 13-Mar-23 to 17-Mar-23.
At the end of the inspection, the company has been issued a "Form 483" with 1 observation, which is procedural in nature. The company will respond to the USFDA within stipulated timeline and work closely with USFDA to address the observation at the earliest.
Shares of Torrent Pharmaceuticals Limited was last trading in BSE at Rs. 1530.50 as compared to the previous close of Rs. 1552.90. The total number of shares traded during the day was 5236 in over 1342 trades.
The stock hit an intraday high of Rs. 1554.10 and intraday low of 1524.55. The net turnover during the day was Rs. 8087331.00.